473731-22-5

Basic information

• Product Name: 3-aMino-2-hydroxy-N-(2-hydroxyethyl)-N-MethylbenzaMide
• Synonyms: 3-aMino-2-hydroxy-N-(2-hydroxyethyl)-N-MethylbenzaMide
• CAS NO: 473731-22-5
• Molecular Formula: C10H14N2O3
• Molecular Weight: 210.22976
• Mol File: 473731-22-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-aMino-2-hydroxy-N-(2-hydroxyethyl)-N-MethylbenzaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-aMino-2-hydroxy-N-(2-hydroxyethyl)-N-MethylbenzaMide(473731-22-5)
• EPA Substance Registry System: 3-aMino-2-hydroxy-N-(2-hydroxyethyl)-N-MethylbenzaMide(473731-22-5)

Safety Data

• Hazardous Substances Data: 473731-22-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Amino-2-hydroxy-N-(2-hydroxyethyl)-N-methylbenzamide is used as a potential drug candidate for various medical conditions due to its analgesic and anti-inflammatory properties. Its unique chemical structure and functionality make it a promising compound for the development of new medications to treat pain and inflammation-related disorders.
Used in Research and Development:
3-Amino-2-hydroxy-N-(2-hydroxyethyl)-N-methylbenzamide is used in research and development for further exploration of its pharmaceutical potential. Its unique properties and chemical structure make it an interesting subject for scientists to study and develop new therapeutic applications, potentially leading to the creation of innovative medications for various health conditions.

Relevant articles and documents

THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of Formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of Formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.